LOS
ANGELES, Jan. 2, 2025 /PRNewswire/ -- The DJS Law
Group reminds investors of a class action lawsuit against
Humacyte, Inc. ("HUMA" or "the Company") (NASDAQ: HUMA) for
violations of the federal securities laws.
Shareholders who bought the Company's securities between
May 10, 2024, and October 17, 2024, inclusive (the "Class Period"),
are encouraged to contact DJS Law Group before January 17, 2025.
CASE DETAILS: According to the Complaint, Humacyte
allegedly made false statements regarding it failure
to maintain good manufacturing practices including with its
microbial testing at its Durham, North
Carolina facility. The FDA's review of the Company's
Biologic License Application (BLA) would be delayed while it fixed
its manufacturing problems.
If you are a shareholder who suffered a loss, contact us to
participate.
WHY DJS LAW GROUP? DJS Law Group's primary focus is
to enhance investor return through balanced counseling and
aggressive advocacy. We specialize in securities class actions,
corporate governance litigation, and domestic/international M&A
appraisals. Our clients are some of the largest and most
sophisticated hedge funds and alternative asset managers in the
world. The litigation claims of our clients are extraordinarily
valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
CONTACT:
David J.
Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/humacyte-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--huma-302341058.html
SOURCE DJS Law Group LLP